BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38040277)

  • 1. Impact of Parathyroidectomy Versus Oral Cinacalcet on Bone Mineral Density in Patients on Peritoneal Dialysis With Advanced Secondary Hyperparathyroidism: The PROCEED Pilot Randomized Trial.
    Wang AY; Tang TK; Yau YY; Lo WK
    Am J Kidney Dis; 2024 Apr; 83(4):456-466.e1. PubMed ID: 38040277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parathyroidectomy versus oral cinacalcet on cardiovascular parameters in peritoneal dialysis patients with advanced secondary hyperparathyroidism (PROCEED): a randomized trial.
    Wang AY; Lo WK; Cheung SC; Tang TK; Yau YY; Lang BH
    Nephrol Dial Transplant; 2023 Jul; 38(8):1823-1835. PubMed ID: 36869794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of anti-osteoporotic treatment after successful parathyroidectomy for primary hyperparathyroidism: a randomized, double-blind, placebo-controlled trial.
    Niederle MB; Foeger-Samwald U; Riss P; Selberherr A; Scheuba C; Pietschmann P; Niederle B; Kerschan-Schindl K
    Langenbecks Arch Surg; 2019 Sep; 404(6):681-691. PubMed ID: 31451913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and risk factors for osteopenia in dialysis patients.
    Stein MS; Packham DK; Ebeling PR; Wark JD; Becker GJ
    Am J Kidney Dis; 1996 Oct; 28(4):515-22. PubMed ID: 8840940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone mineral density and its correlation with clinical and laboratory factors in chronic peritoneal dialysis patients.
    Ersoy FF; Passadakis SP; Tam P; Memmos ED; Katopodis PK; Ozener C; Akçiçek F; Camsari T; Ateş K; Ataman R; Vlachojannis JG; Dombros AN; Utaş C; Akpolat T; Bozfakioğlu S; Wu G; Karayaylali I; Arinsoy T; Stathakis PC; Yavuz M; Tsakiris JD; Dimitriades CA; Yilmaz ME; Gültekin M; Karayalçin B; Yardimsever M; Oreopoulos DG
    J Bone Miner Metab; 2006; 24(1):79-86. PubMed ID: 16369903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone mineral recovery after parathyroidectomy in patients with primary and renal hyperparathyroidism.
    Abdelhadi M; Nordenström J
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3845-51. PubMed ID: 9814456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Denosumab and cinacalcet for primary hyperparathyroidism (DENOCINA): a randomised, double-blind, placebo-controlled, phase 3 trial.
    Leere JS; Karmisholt J; Robaczyk M; Lykkeboe S; Handberg A; Steinkohl E; Brøndum Frøkjær J; Vestergaard P
    Lancet Diabetes Endocrinol; 2020 May; 8(5):407-417. PubMed ID: 32333877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parathyroidectomy can improve bone mineral density in patients with symptomatic secondary hyperparathyroidism.
    Chou FF; Chen JB; Lee CH; Chen SH; Sheen-Chen SM
    Arch Surg; 2001 Sep; 136(9):1064-8. PubMed ID: 11529832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paricalcitol- or cinacalcet-centred therapy affects markers of bone mineral disease in patients with secondary hyperparathyroidism receiving haemodialysis: results of the IMPACT-SHPT study.
    Cozzolino M; Ketteler M; Martin KJ; Sharma A; Goldsmith D; Khan S
    Nephrol Dial Transplant; 2014 Apr; 29(4):899-905. PubMed ID: 24500308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in prevalence of reduced and low bone mineral density between lumbar spine and femoral neck in peritoneal dialysis patients using dual-energy X-ray absorptiometry (DXA).
    Davenport A
    Perit Dial Int; 2023 Jul; 43(4):334-338. PubMed ID: 36627766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Effectiveness of Alternative Treatment Approaches to Secondary Hyperparathyroidism in Patients Receiving Maintenance Hemodialysis: An Observational Trial Emulation.
    Platt A; Wilson J; Hall R; Ephraim PL; Morton S; Shafi T; Weiner DE; Boulware LE; Pendergast J; Scialla JJ;
    Am J Kidney Dis; 2024 Jan; 83(1):58-70. PubMed ID: 37690631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the Increase in Bone Mineral Density After Surgical Treatment of Primary Hyperparathyroidism.
    Mendoza-Moreno F; Díez-Alonso M; Ovejero-Merino E; Sánchez-Gollarte A; Alvarado-Hurtado R; Matías-García B; Rodríguez-Pascual Á; Medina-Reinoso C; Ratia-Jiménez T; Hernández-Merlo F; Granell-Vicent J
    J Clin Densitom; 2019; 22(2):171-178. PubMed ID: 30482495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in bone mineral density after total parathyroidectomy without autotransplantation in the end-stage renal disease patients with secondary hyperparathyroidism.
    Fang L; Wu J; Luo J; Wen P; Xiong M; Cao J; Chen X; Yang J
    BMC Nephrol; 2018 Jun; 19(1):142. PubMed ID: 29907149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parathyroidectomy Improves Bone Density in Women With Primary Hyperparathyroidism and Preoperative Osteopenia.
    Frey S; Gérard M; Guillot P; Wargny M; Bach-Ngohou K; Bigot-Corbel E; Renaud Moreau N; Caillard C; Mirallié E; Cariou B; Blanchard C
    J Clin Endocrinol Metab; 2024 May; 109(6):1494-1504. PubMed ID: 38152848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen replacement may be an alternative to parathyroid surgery for the treatment of osteoporosis in elderly postmenopausal women presenting with primary hyperparathyroidism: a preliminary report.
    Diamond T; Ng AT; Levy S; Magarey C; Smart R
    Osteoporos Int; 1996; 6(4):329-33. PubMed ID: 8883124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An open-label, prospective pilot clinical study of denosumab for severe hyperparathyroidism in patients with low bone mass undergoing dialysis.
    Chen CL; Chen NC; Hsu CY; Chou KJ; Lee PT; Fang HC; Renn JH
    J Clin Endocrinol Metab; 2014 Jul; 99(7):2426-32. PubMed ID: 24670088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parathyroidectomy for adults with primary hyperparathyroidism.
    Pappachan JM; Lahart IM; Viswanath AK; Borumandi F; Sodi R; Metzendorf MI; Bongaerts B
    Cochrane Database Syst Rev; 2023 Mar; 3(3):CD013035. PubMed ID: 36883976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Secondary Hyperparathyroidism and Posttransplant Tertiary Hyperparathyroidism.
    Egan CE; Qazi M; Lee J; Lee-Saxton YJ; Greenberg JA; Beninato T; Zarnegar R; Fahey TJ; Finnerty BM
    J Surg Res; 2023 Nov; 291():330-335. PubMed ID: 37506432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of cinacalcet treatment on vascular arterial stiffness among peritoneal dialysis patients with secondary hyperparathyroidism.
    Chow KM; Szeto CC; Kwan BC; Cheng PM; Pang WF; Leung CB; Li PK
    Nephrology (Carlton); 2014 Jun; 19(6):339-44. PubMed ID: 24589316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of parathyroidectomy for primary hyperparathyroidism on bone mineral density in postmenopausal women.
    Sitges-Serra A; García L; Prieto R; Peña MJ; Nogués X; Sancho JJ
    Br J Surg; 2010 Jul; 97(7):1013-9. PubMed ID: 20632266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.